Psychotic features associated with multiple sclerosis

References

• Asghar-Ali AA, Taber KH, Hurley RA, Hayman LA. Pure neuropsychiatric presentation of multiple sclerosis. American Journal of Psychiatry 2004; 161: 226–231
   PubMed Web of Science ®Google Scholar
• Bloch M, Gur E, Shalev A. Chlorpromazine prophylaxis of steroid-induced psychosis. General Hospital Psychiatry 1994; 16: 42–44
   PubMed Web of Science ®Google Scholar
• Brinar V, Zadro I. Psychic manifestations in multiple sclerosis and other idiopathic demyelinating diseases of central nervous system. Neurologia Croatica 2007; 56: 82–87
   Google Scholar
• Carson HJ, Searle-White DJ. Occult multiple sclerosis presenting with psychosis. The Canadian Journal of Psychiatry 1996; 41: 486–487
   PubMedGoogle Scholar
• Chong S, Ko S. Clozapine treatment of psychosis associated with multiple sclerosis. Canadian Journal of Psychiatry 1997; 42: 90–91
   PubMed Web of Science ®Google Scholar
• Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: Epidemiological study of a large community sample. American Journal of Psychiatry 2002; 159: 1862–1868
   PubMed Web of Science ®Google Scholar
• Clarke T, Wadhwa U, Leroi I. Psychotic depression. An atypical initial presentation of multiple sclerosis. Psychosomatics 1998; 39: 72–75
   PubMedGoogle Scholar
• Cordess C, Folstein M, Drachman D. Psychiatric effects of alternate-day steroid therapy. British Journal of Psychiatry 1981; 138: 504–506
   PubMedGoogle Scholar
• Davids E, Hartwig U, Gastpar M. Antipsychotic treatment of psychosis associated with multiple sclerosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2004; 28: 743–744
   PubMed Web of Science ®Google Scholar
• Davison K, Bagley CR. Schizophrenia-like psychosis associated with organic disorders of the central nervous system. A review of the literature. Current problems in neuropsychiatry, HR Herrington. Hedley Brothers, Ashford, Kent 1969; 113–184
   Google Scholar
• Diaz-Olavarrieta C, Cummings JL, Velazquez J, Garcia de la Cadena C. Neuropsychiatric manifestations of multiple sclerosis. Journal of Neuropsychiatry and Clinical Neuroscience 1999; 11: 51–57
   PubMed Web of Science ®Google Scholar
• Drake ME. Acute paranoid psychosis in multiple sclerosis. Psychosomatics 1984; 25: 60–65
   PubMed Web of Science ®Google Scholar
• Feinstein A. The clinical neuropsychiatry of multiple sclerosis. Cambridge University Press, New York, NY 1999
   Google Scholar
• Feinstein A, du Boulay G, Ron MA. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. British Journal of Psychiatry 1992; 161: 680–685
   PubMed Web of Science ®Google Scholar
• Feinstein A, Roy P, Lobaugh N, Feinstein KJ, O’Connor P. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 2004; 62: 586–590
   PubMed Web of Science ®Google Scholar
• Felgenhauer K. Psychiatric disorders in the encephalitic form of multiple sclerosis. Journal of Neurology 1990; 237: 11–18
   PubMedGoogle Scholar
• Fricchione GL, Carbone L, Bennett WI. Psychotic disorders caused by a general medical condition, with delusions. Secondary ‘organic’ delusional syndromes. The Psychiatric Clinics of North America 1995; 18: 363–378
   PubMed Web of Science ®Google Scholar
• Gardner-Thorpe C, Pearn J. The Cotard syndrome. Report of two cases: With a review of the extended spectrum of ‘délire des négations’. European Journal of Neurology 2004; 11: 563–566
   PubMedGoogle Scholar
• Garfield DA. Multiple sclerosis and affective disorder: Two case reports of mania with psychosis. Psychotherapy and Psychosomatics 1985; 44: 25–33
   PubMed Web of Science ®Google Scholar
• Georgopoulou E, Bornibelli C, Choustoulakis I, Alivanis P. Psychosis in a multiple sclerosis patient and antipsychotic treatment. Annals of General Psychiatry 2008; 7: S254
   Google Scholar
• Goeb J-L, Cailleau A, Laine P, Etcharry-Bouyx, Maugin D, Duverger P, et al. Acute delirium, delusion and depression during INF-β-1a therapy for multiple sclerosis: A case report. Clinical Neuropharmacology 2003; 26: 5–7
   PubMed Web of Science ®Google Scholar
• Goeb J-L, Even C, Nikolas G, Gohier B, Dubas F, Garre JB. Psychiatric side effects of interfern-β in multiple sclerosis. European Psychiatry 2006; 21: 186–193
   PubMed Web of Science ®Google Scholar
• Goggans FC, Weisberg LJ, Koran LM. Lithium prophylaxis of prednisone psychosis: A case report. Journal of Clinical Psychiatry 1983; 44: 111–112
   PubMedGoogle Scholar
• Habek M, Brinar M, Brinar VV, Poser CM. Psychiatric manifestation of multiple sclerosis and acute disseminated encephalomyelitis. Clinical Neurology and Neurosurgery 2006; 108: 290–294
   PubMedGoogle Scholar
• Harel Y, Barak Y, Achiron A. Dysregulation of affect in multiple sclerosis: New phenomenological approach. Psychiatry and Clinical Neurosciences 2007; 61: 94–98
   Google Scholar
• Heckers S, Anick D, Boverman JF, Stern TA. Priapism following olanzapine administration in a patient with multiple sclerosis. Psychosomatics 1998; 39: 288–290
   PubMed Web of Science ®Google Scholar
• Himmerich H, Szegeli A, Klawe C, Anghelescu I, Muller MJ. Distigmine bromide induced acute psychotic disorder in a patients with multiple sclerosis. European Psychiatry 2003; 18: 318–319
   PubMedGoogle Scholar
• Honer WG, Hurwitz T, Li DKB, Parmer M, Paty DW. Temporal lobe involvement in multiple sclerosis patients with psychiatric disorders. Archives of Neurology 1987; 44: 187–190
   PubMedGoogle Scholar
• Hussain A, Belderbos S. Risperidone depot in the treatment of psychosis associated with multiple sclerosis – A case report. Journal of Psychopharmacology 2008; 22: 925–926
   PubMedGoogle Scholar
• Hutchinson M, Stack J, Buckley P. Bipolar affective disorder prior to the onset of multiple sclerosis. Acta Neurologca Scandinavica 1993; 88: 388–393
   PubMed Web of Science ®Google Scholar
• Jensen I, Larson JK. Mental aspects of temporal lobe epilepsy: Follow-up of 74 patients after resection of a temporal lobe. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 256–265
   PubMed Web of Science ®Google Scholar
• Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z. Personal and family history of affective disorder in patients with multiple sclerosis. Journal of Affective Disorders 1987; 12: 63–65
   PubMed Web of Science ®Google Scholar
• Jongen PJH. Psychiatric onset of multiple sclerosis. Journal of Neurological Sciences 2006; 24: 59–62
   Google Scholar
• Kershner P, Wang-Cheng C. Psychiatric side effects of steroid therapy. Psychosomatics 1989; 30: 135–139
   PubMed Web of Science ®Google Scholar
• Kumar T, Singh J. Delusion of parasitosis: An atypical initial presentation of multiple sclerosis. Hong Kong Journal of Psychiatry 2009; 19: 42–45
   Google Scholar
• Lautenschlager NT, Forstl H. Organic psychosis: Insights into the biology of psychosis. Current Psychiatry Reports 2001; 3: 319–325
   PubMedGoogle Scholar
• Lewis DA, Smith RE. Steroid-induced psychiatric syndromes: A report of 14 cases and a review of the literature. Journal of Affective Disorders 1983; 5: 319–332
   PubMed Web of Science ®Google Scholar
• Lyoo IK, Seol HY, Byun HS, Renshaw PF. Unsuspected multiple sclerosis in patients with psychiatric disorders: A magnetic resonance imaging study. Journal of Neuropsychiatry and Clinical Neuroscience 1996; 8: 54–59
   PubMed Web of Science ®Google Scholar
• Matthews WB. Multiple sclerosis presenting with acute remitting psychiatric symptoms. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 859–863
   PubMedGoogle Scholar
• Mendez MF. Multiple sclerosis presenting as catatonia. International Journal of Psychiatry 1999; 29: 435–441
   Google Scholar
• Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Archives of Neurology 1990; 54: 531–533
   Google Scholar
• Modrego PJ, Ferrandez J. Familial multiple sclerosis with repetitive relapses of manic psychosis in two patients (mother and daughter). Behavioural Neurology 2000; 12: 175–179
   PubMedGoogle Scholar
• Myint AM, Schwarz MJ, Steinbusch HWM, Leonard BE. Neuropsychiatric disorders related to interferon and interleukins treatment. Metabolic Brain Disorders 2009; 24: 55–68
   PubMed Web of Science ®Google Scholar
• Patten SB, Svenson LW, Metz M. Psychotic disorders in multiple sclerosis: Population-based evidence of an association. Neurology 2005; 65: 1123–1125
   PubMed Web of Science ®Google Scholar
• Pine DS, Douglas CJ, Charles E, Davies M, Kahn D. Patients with multiple sclerosis presenting to psychiatric hospitals. Journal of Clinical Psychiatry 1995; 56: 297–306
   PubMed Web of Science ®Google Scholar
• Reimer J, Aderhold V, Lambert M, Haasen C. Manifestation of multiple sclerosis with paranoid-hallucinatory psychosis. Journal of Neurology 2006; 253: 531–532
   PubMedGoogle Scholar
• Reiss JP, Sam D, Sareen J. Psychosis in multiple sclerosis associated with left temporal lobe lesions on serial MRI scans. Journal of Clinical Neuroscience (Case Reports) 2006; 13: 282–284
   PubMedGoogle Scholar
• Ron MA, Logsdail SJ. Psychiatric morbidity in multiple sclerosis: A clinical and MRI study. Psychological Medicine 1989; 19: 887–895
   PubMed Web of Science ®Google Scholar
• Sabet-Sharghi F, Hutzler JC. Prophylaxis of steroid-induced psychiatric symptoms. Psychosomatics 1990; 31: 113
   PubMedGoogle Scholar
• Safferman AZ, Kane JM, Aronowitz JS, Pollack S, Lieberman JA. The use of clozapine in neurologic disorders. Journal of Clinical Psychiatry 1994; 55: 98S–101S
   PubMed Web of Science ®Google Scholar
• Schiffer RB, Babigian HM. Behavioral disturbance in multiple sclerosis, temporal lobe epilepsy and amyotrophic lateral sclerosis: An epidemiologic study. Archives of Neurology 1984; 41: 1067–1069
   PubMed Web of Science ®Google Scholar
• Sechi GP, Piras MR, Demurtas A, Tamca S, Rosati G. Dexamethasone-induced schizoaffective-like state in multiple sclerosis: Prophylaxis and treatment with carbamazepine. Clinical Neuropharmacology 1987; 5: 453–457
   Google Scholar
• Sidoti V, Lorusso L. Multiple sclerosis and Capgras’ syndrome. Clinical Neurology and Neurosurgery 2007; 109: 786–787
   PubMed Web of Science ®Google Scholar
• Smith EJ. Multiple sclerosis presenting with erotomanic delusions in the context of ‘don't ask, don't tell’. Military Medicine 2009; 174: 297–298
   PubMedGoogle Scholar
• Stevens JR. Psychosis and the temporal lobe. Advances in neurology, D Smith, D Treiman, M Trimble. Raven Press, New York 1991; 79–96
   Google Scholar
• Surridge D. An investigation into some psychiatric aspects of multiple sclerosis. British Journal of Psychiatry 1969; 115: 749–764
   PubMed Web of Science ®Google Scholar
• Thöne J, Kessler E. Improvement of neuropsychiatric symptoms in multiple sclerosis subsequent to high-dose corticosteroid treatment. Primary Care Companion Journal of Clinical Psychiatry 2008; 10: 163–164
   PubMedGoogle Scholar